These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38911067)

  • 1. Integrin αM promotes macrophage alternative M2 polarization in hyperuricemia-related chronic kidney disease.
    Liu J; Guo F; Chen X; Fu P; Ma L
    MedComm (2020); 2024 Jul; 5(7):e580. PubMed ID: 38911067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.
    Jeon HJ; Oh J; Shin DH
    PLoS One; 2019; 14(6):e0218510. PubMed ID: 31206563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the SGK3/TOPK signaling pathway in the transition from acute kidney injury to chronic kidney disease.
    Shu H; Wang Y; Zhang H; Dong Q; Sun L; Tu Y; Liao Q; Feng L; Yao L
    Front Pharmacol; 2023; 14():1169054. PubMed ID: 37361201
    [No Abstract]   [Full Text] [Related]  

  • 5. Paeoniflorin suppresses kidney inflammation by regulating macrophage polarization via KLF4-mediated mitophagy.
    Cao Y; Xiong J; Guan X; Yin S; Chen J; Yuan S; Liu H; Lin S; Zhou Y; Qiu J; Wang D; Liu B; Zhou J
    Phytomedicine; 2023 Jul; 116():154901. PubMed ID: 37247587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
    Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease.
    Sellmayr M; Hernandez Petzsche MR; Ma Q; Krüger N; Liapis H; Brink A; Lenz B; Angelotti ML; Gnemmi V; Kuppe C; Kim H; Bindels EMJ; Tajti F; Saez-Rodriguez J; Lech M; Kramann R; Romagnani P; Anders HJ; Steiger S
    J Am Soc Nephrol; 2020 Dec; 31(12):2773-2792. PubMed ID: 32938648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage in chronic kidney disease.
    Guiteras R; Flaquer M; Cruzado JM
    Clin Kidney J; 2016 Dec; 9(6):765-771. PubMed ID: 27994852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced M1 and Impaired M2 Macrophage Polarization and Reduced Mitochondrial Biogenesis via Inhibition of AMP Kinase in Chronic Kidney Disease.
    Li C; Ding XY; Xiang DM; Xu J; Huang XL; Hou FF; Zhou QG
    Cell Physiol Biochem; 2015; 36(1):358-72. PubMed ID: 25967974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization.
    Hu X; Xu Y; Zhang Z; Tang Z; Zhang J; Luo Y; Deng W; Dong Z; Zhao Y; Na N
    Front Immunol; 2021; 12():637335. PubMed ID: 33767704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease.
    Tiku A; Johnson DW; Badve SV
    Curr Opin Nephrol Hypertens; 2021 May; 30(3):346-352. PubMed ID: 33767063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages.
    Shinoda Y; Tatsukawa H; Yonaga A; Wakita R; Takeuchi T; Tsuji T; Tanaka M; Suganami T; Hitomi K
    Cell Death Dis; 2023 Mar; 14(2):136. PubMed ID: 36864028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.
    Zhou X; Chen H; Hu Y; Ma X; Li J; Shi Y; Tao M; Wang Y; Zhong Q; Yan D; Zhuang S; Liu N
    Cell Death Dis; 2023 Apr; 14(4):253. PubMed ID: 37029114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Migratory Properties of M1, M2, and Resident Macrophages Are Regulated by α
    Cui K; Ardell CL; Podolnikova NP; Yakubenko VP
    Front Immunol; 2018; 9():2650. PubMed ID: 30524429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of Serum Uric Acid Associated with Attenuation of Renal Injury, Inflammation and Macrophages M1/M2 Ratio in Hyperuricemic Mice Model.
    Haryono A; Nugrahaningsih DAA; Sari DCR; Romi MM; Arfian N
    Kobe J Med Sci; 2018 Oct; 64(3):E107-E114. PubMed ID: 30666040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenic role of succinate-SUCNR1: a critical function that induces renal fibrosis via M2 macrophage.
    Pu M; Zhang J; Hong F; Wang Y; Zhang C; Zeng Y; Fang Z; Qi W; Yang X; Gao G; Zhou T
    Cell Commun Signal; 2024 Jan; 22(1):78. PubMed ID: 38291510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α
    Zhang Y; Shi X; Han J; Peng W; Fang Z; Zhou Y; Xu X; Lin J; Xiao F; Zhao L; Lin Y
    Drug Des Devel Ther; 2021; 15():803-812. PubMed ID: 33654384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage promotes fibroblast activation and kidney fibrosis by assembling a vitronectin-enriched microenvironment.
    Peng Y; Li L; Shang J; Zhu H; Liao J; Hong X; Hou FF; Fu H; Liu Y
    Theranostics; 2023; 13(11):3897-3913. PubMed ID: 37441594
    [No Abstract]   [Full Text] [Related]  

  • 19. MSR1 characterized by chromatin accessibility mediates M2 macrophage polarization to promote gastric cancer progression.
    Chen X; Jiang J; Liu H; Li A; Wang W; Ni Z; Lin M
    Int Immunopharmacol; 2022 Nov; 112():109217. PubMed ID: 36095948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis.
    Jiao B; An C; Tran M; Du H; Wang P; Zhou D; Wang Y
    Front Immunol; 2021; 12():735014. PubMed ID: 34512669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.